Company intelligence / Profile preview

Blueclinical

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Blueclinical has conducted clinical trials including a Phase 2 study evaluating dolutegravir plus 2 NRTIs in treatment-naïve HIV-2 infected subjects. The company operates in three main areas: Phase I studies, R&D support, and clinical research partnerships.

Therapeutic areas: Infectious Diseases
Industry: Contract Research Organization

Partnerships

Vensica Therapeutics (clinical trial collaboration)

Beyond the preview

Go deeper on Blueclinical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blueclinical.